Studies and documentation
Our Clinical Department has been conducting AMG and MPG studies for a long time. These range from phase II - IV as well as purely observational studies. The study documentation section also includes the documentation for transplants that is required by law.
Our Clinical Department has been participating in various drug studies in the field of transplantation for many years.
We are currently actively involved in
-
EnGraft - LTX study (in cooperation with the University Hospital Regensburg),
A multi-center, open, randomized, parallel, two-arm superiority study to investigate the bioavailability and handling of Envarsus®compared to Advagraf®in de novolivertransplant recipients (EnGraft). Recruitment almost completed
-
TaCDrop - NTX study (in collaboration with the University Hospital Regensburg),
Multicenter, open label, randomized, two-arm, parallel-group, superiority trial to assess bioavailability and practicability of two once-daily tacrolimus formulations, Envarsus ® compared with Advagraf, administered in kidney recipients. - Study start planned
-
HOPE perfusion study - in collaboration with Charité Berlin
End-ischaemic hypothermic oxygenated (HOPE) versus normothermic machine perfusion (NMP) compared to conventional cold storage in donation after brain daith (DBD) liver transplantation; a prospective multicenter randomized controlled trial(HOPE-NMP), study start planned
If you are interested in participating in one of the studies, please contact us.
The contact persons are
☎ 0511 532 - 4091, Fax: 0511 532 - 4096
Stadtfelddamm 65, 30625 Hanover, Germany
Building K25 / 2nd floor / Room 2050
We are involved in various visceral oncology studies. Currently these are
-
Metapanc study
in collaboration with the University of Göttingen (intensified treatment in patients with oligometastatic pancreatic cancer - multimodal surgical treatment versus systemic chemotherapy alone - a randomized, controlled study), study start planned
-
Mircast - study
in collaboration with the company IDIVAL (Spain), (Minimally Invasive Right Colectomy Anastomosis Study) Completion - no further inclusion possible
-
Pro-duct002 - Study
in collaboration with Charité - Microscopic tumor freedom after liver transplantation for central bile duct carcinoma, study start planned
-
ARMANI - Study
multicenter study in collaboration with the University of Dresden (anatomical resection of liver metastases in patients with RAS-mutated coloretal carcinoma - a randomized controlled trial), study start planned
If you are interested in participating in one of the studies, please contact us.
The contact persons are
☎ 0511 532 - 4091, Fax: 0511 532 - 4096
Stadtfelddamm 65, 30625 Hanover, Germany
Building K25 / 2nd floor / Room 2050
IQTIG: The is the Institutefor Quality Assuranceand Transparency in Healthcare.
The quality report records and evaluates all data on transplantations performed in our Clinical Department.
Responsible for this is
- Mandy Rehm
- Deputy Christel Koczur and Regine Pfeiffer
☎ 0511 532 - 6787, Fax: 0511 532 - 4010, Mobile 01761 532 - 2572
There are several other documentations, some of which are prescribed by law.
- Eurotransplant documentation (responsible Christel Koczur and Regine Pfeiffer)
- CTS documentation (responsible Christel Koczur and Regine Pfeiffer)
- DGAV-StuDoQ | Robotic - Study, Documentation and Quality Center of the German Society for General and Visceral Surgery (DGAV) for operations in the field of visceral oncology and general surgery (responsible Kathrin Reinsch)